{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:16:16Z","timestamp":1776327376592,"version":"3.50.1"},"reference-count":28,"publisher":"FapUNIFESP (SciELO)","issue":"suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>SUMMARY Sickle-cell diseases are the most common inherited hemoglobinopathies worldwide. Improvement in survival has been seen in the last decades with the introduction of careful screening and prevention of complications and the introduction of hydroxyurea. Stem-cell transplantation is currently the only curative option for these patients and has been indicated for patients with neurological events, repeated vaso-occlusive crisis, any organ damage or presence of red blood cell antibodies. Related bone-marrow or cord-blood transplant has shown an overall survival of more than 90% with a disease-free survival of 90% in 1,000 patients transplanted in the last decades. The use of unrelated donors unfortunately has not shown the same good results, but better typing methods and improved support may improve the outcome with this source of stem cells in the future. In Brazil, only recently stem cell transplant from related donors has been included in the procedures performed in the public health system. The use of related bone marrow or cord blood and a myeloablative conditioning regimen are considered standard of care for patients with sickle-cell diseases. Transplants with non-myeloablative regimens, unrelated donors or haploidentical donors should be performed only in controlled clinical trials.<\/jats:p>","DOI":"10.1590\/1806-9282.62.suppl1.16","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T22:01:07Z","timestamp":1481148067000},"page":"16-22","source":"Crossref","is-referenced-by-count":7,"title":["Allogenic bone narrow transplantation in sickle-cell diseases."],"prefix":"10.1590","volume":"62","author":[{"given":"Belinda Pinto","family":"Sim\u00f5es","sequence":"first","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiano","family":"Pieroni","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thalita","family":"Costa","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Navarro","family":"Barros","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Darrigo Jr.","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Settani","family":"Grecco","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Elias","family":"Bernardes","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Moraes","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Beatriz Lima","family":"Stracieri","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Cunha","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carolina","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"USP, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"22","key":"ref1","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"Weatherall DJ","year":"2010","journal-title":"Blood"},{"issue":"9757","key":"ref2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees DC","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcmd.2014.08.007","article-title":"Cerebral vasculopathy in children with sickle cell anemia","volume":"54","author":"Fasano RM","year":"2015","journal-title":"Blood cells, Blood Cells Mol Dis"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(06)70469-0","article-title":"Pathophysiology and treatment of stroke in sickle-cell disease: present and future","volume":"5","author":"Switzer JA","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/ehm.13.25","article-title":"Stroke in patients with sickle cell disease","volume":"6","author":"Webb J","year":"2013","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjh.12950","article-title":"The spleen and sickle cell disease: the sick(led) spleen","volume":"166","author":"Brousse V","year":"2014","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"ref7","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.2119\/molmed.2014.00187","article-title":"Advances in sickle cell therapies in the hydroxyurea era","volume":"20","author":"Field JJ","year":"2014","journal-title":"Mol Med"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1535370216640385","article-title":"Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication","volume":"241","author":"Quinn CT","year":"2016","journal-title":"Exp Biol Med"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5581\/1516-8484.20110014","article-title":"Brazilian Guidelines for transcranial doppler in children and adolescents with sickle cell disease","volume":"33","author":"Lobo CL","year":"2011","journal-title":"Rev Bras Hematol Hermoter"},{"issue":"5 Suppl","key":"ref10","first-page":"266","article-title":"[Bone marrow transplant in thalassemia. The Pesaro experience]","volume":"74","author":"Lucarelli G","year":"1989","journal-title":"Haematologica"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2015.10.017","article-title":"Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease","volume":"22","author":"Walters MC","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci E","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk VR","year":"2016","journal-title":"Blood"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM198409203111207","article-title":"Bone-marrow transplantation in a patient with sickle-cell anemia","volume":"311","author":"Johnson FL","year":"1984","journal-title":"N Engl J Med"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters MC","year":"1996","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"ref16","first-page":"116","article-title":"Bone marrow transplantation in sickle cell disease: the Belgian experience","volume":"12","author":"Vermylen C","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00062752-199603020-00010","article-title":"Bone marrow transplantation for sickle cell anemia","volume":"3","author":"Vermylen C","year":"1996","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 1","key":"ref18","first-page":"118","article-title":"Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO","volume":"12","author":"Bernaudin F","year":"1993","journal-title":"Bone Marrow Transplantat"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin F","year":"2007","journal-title":"Blood"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06592.x","article-title":"Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research","volume":"137","author":"Panepinto JA","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bjh.13352","article-title":"Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease","volume":"169","author":"Strocchio L","year":"2015","journal-title":"Br J Haematol"},{"issue":"23","key":"ref22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1182\/blood.V126.23.541.541","article-title":"Hematopoietic Stem Cell Transplantation from HLA Identical Sibling For sickle Cell Disease an International Survey on Behalf of Eurocord-Monacord, EBMT Pediatric Disease Working Party and CIBMTR","volume":"126","author":"Cappelli BB","year":"2015","journal-title":"Blood"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh MM","year":"2014","journal-title":"JAMA"},{"issue":"24","key":"ref24","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1056\/NEJMoa0904971","article-title":"Allogeneic hematopoietic stem-cell transplantation for sickle cell disease","volume":"361","author":"Hsieh MM","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.hoc.2014.08.014","article-title":"Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions","volume":"28","author":"Fitzhugh CD","year":"2014","journal-title":"Hematol Oncol Clin North Am"},{"issue":"22","key":"ref26","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bolanos-Meade J","year":"2012","journal-title":"Blood"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bjhh.2014.11.009","article-title":"Trends in mortality and hospital admissions of sickle cell disease patients before and after the newborn screening program in Maranhao, Brazil","volume":"37","author":"Lima AR","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/20469047.2015.1109235","article-title":"Survival of children with sickle cell disease in the comprehensive newborn screening programme in Minas Gerais, Brazil","volume":"35","author":"Sabarense AP","year":"2015","journal-title":"Paediatr Int Child Health"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ramb\/v62s1\/0104-4230-ramb-62-s1-0016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T15:26:55Z","timestamp":1657985215000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302016001200016&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":28,"journal-issue":{"issue":"suppl 1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0104-42302016001200016"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.62.suppl1.16","relation":{},"ISSN":["0104-4230"],"issn-type":[{"value":"0104-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}